Ensysce Biosciences Stock Market Value
| ENSC Stock | USD 6.93 0.22 3.08% |
| Symbol | Ensysce |
Ensysce Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensysce Biosciences. If investors know Ensysce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensysce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.10) | Revenue Per Share | Quarterly Revenue Growth (0.63) | Return On Assets | Return On Equity |
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensysce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ensysce Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ensysce Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ensysce Biosciences.
| 11/02/2024 |
| 01/31/2025 |
If you would invest 0.00 in Ensysce Biosciences on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding Ensysce Biosciences or generate 0.0% return on investment in Ensysce Biosciences over 90 days. Ensysce Biosciences is related to or competes with Zura Bio, Phio Pharmaceuticals, Sonnet Biotherapeutics, 180 Life, Cardio Diagnostics, Virax Biolabs, and Revelation Biosciences. Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for... More
Ensysce Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ensysce Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ensysce Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.31 | |||
| Information Ratio | 0.0649 | |||
| Maximum Drawdown | 81.06 | |||
| Value At Risk | (10.97) | |||
| Potential Upside | 24.85 |
Ensysce Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ensysce Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ensysce Biosciences' standard deviation. In reality, there are many statistical measures that can use Ensysce Biosciences historical prices to predict the future Ensysce Biosciences' volatility.| Risk Adjusted Performance | 0.0703 | |||
| Jensen Alpha | 0.9342 | |||
| Total Risk Alpha | (0.44) | |||
| Sortino Ratio | 0.0971 | |||
| Treynor Ratio | (2.20) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ensysce Biosciences Backtested Returns
At this point, Ensysce Biosciences is unstable. Ensysce Biosciences secures Sharpe Ratio (or Efficiency) of close to zero, which denotes the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Ensysce Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Ensysce Biosciences' Mean Deviation of 8.9, coefficient of variation of 1370.51, and Downside Deviation of 8.31 to check if the risk estimate we provide is consistent with the expected return of 0.0746%. The firm shows a Beta (market volatility) of -0.41, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Ensysce Biosciences are expected to decrease at a much lower rate. During the bear market, Ensysce Biosciences is likely to outperform the market. Ensysce Biosciences right now shows a risk of 9.81%. Please confirm Ensysce Biosciences semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Ensysce Biosciences will be following its price patterns.
Auto-correlation | 0.66 |
Good predictability
Ensysce Biosciences has good predictability. Overlapping area represents the amount of predictability between Ensysce Biosciences time series from 2nd of November 2024 to 17th of December 2024 and 17th of December 2024 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ensysce Biosciences price movement. The serial correlation of 0.66 indicates that around 66.0% of current Ensysce Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.78 |
Ensysce Biosciences lagged returns against current returns
Autocorrelation, which is Ensysce Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ensysce Biosciences' stock expected returns. We can calculate the autocorrelation of Ensysce Biosciences returns to help us make a trade decision. For example, suppose you find that Ensysce Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ensysce Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ensysce Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ensysce Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ensysce Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Ensysce Biosciences Lagged Returns
When evaluating Ensysce Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ensysce Biosciences stock have on its future price. Ensysce Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ensysce Biosciences autocorrelation shows the relationship between Ensysce Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Ensysce Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ensysce Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ensysce Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ensysce Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ensysce Biosciences Stock:Check out Ensysce Biosciences Correlation, Ensysce Biosciences Volatility and Ensysce Biosciences Alpha and Beta module to complement your research on Ensysce Biosciences. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Ensysce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.